FDA product approval
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
Research compound · compound · checked 2026-10-09
Tesofensine is listed here as a compound. Investigational monoamine reuptake inhibitor affecting noradrenaline, dopamine and serotonin signaling. Status was checked 2026-10-09. This card reports cited facts. It does not tell you to use Tesofensine or how much to take.
Last checked Oct 9, 2026 by PepBear. Not medical advice.
Other names in the library: Tesofensine Capsules — 250mcg, Tesofensine Capsules — 500mcg. Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: 250 mcg, 500 mcg. A seller title is a listing. It does not prove the vial matches a paper.
Investigational monoamine reuptake inhibitor affecting noradrenaline, dopamine and serotonin signaling.
FDA product approval
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
Compounding
not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.
Research
investigational. 203 adults with obesity in a 24-week randomized placebo-controlled trial.
Sport
unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.
We mark the cited papers as B for 203 adults with obesity in a 24-week randomized placebo-controlled trial. and The trial assessed weight loss alongside an energy-restricted diet.. This is a pharmacologically active investigational compound, not an ordinary nutrient. Results do not establish research-capsule quality or general safety. The trial assessed weight loss alongside an energy-restricted diet. This is a pharmacologically active investigational compound, not an ordinary nutrient. Results do not establish research-capsule quality or general safety. Risks on the record: Dry mouth, gastrointestinal effects and cardiovascular changes were assessed in the trial; longer-term safety remains uncertain.
We mark the cited papers as B. That is our label for how strong those papers are. It does not say the compound works.
human-trial
The trial assessed weight loss alongside an energy-restricted diet.
203 adults with obesity in a 24-week randomized placebo-controlled trial. This is a pharmacologically active investigational compound, not an ordinary nutrient. Results do not establish research-capsule quality or general safety.
The catalog does not record a single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.
Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.
U-100 math for listed Tesofensine sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.
| Listed vial | 1 mL liquid | 2 mL liquid | 3 mL liquid |
|---|---|---|---|
| 250 mcg | 2.5 | 1.3 | 0.8 |
| 500 mcg | 5 | 2.5 | 1.7 |
People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.
Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.